Western Alliance Bancorporation (WAL) Stock Price Today
Aura AI Summary
Key Stats
- $9.04BMarket Cap
- -Volume
- FinancialsSector
- $96.0852W High
- $66.7052W Low
- -Typical Hold Time
- -Enterprise Value
- 2.03%Div Yield
- -Trading Activity
Track Western Alliance Bancorporation (WAL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Western Alliance Bancorporation has traded between a low of $66.7 and a high of $96.08, highlighting its annual price range. Buy and sell Western Alliance Bancorporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Most Recent News
Global AI in Medical Coding market to reach $10.6B by 2035 with 13.5% CAGR, driven by healthcare digital transformation.
The global AI in Medical Coding market, valued at $3 billion in 2025, is projected to grow to $10.6 billion by 2035 at a 13.5% CAGR. Growth is fueled by increasing adoption of AI technologies in healthcare for automated coding, fraud detection, and r...
OMODA 4 debuts in Southeast Asia with AI cockpit tech, targeting young users and smart mobility growth.
OMODA & JAECOO launched the OMODA 4 SUV in Southeast Asia at the OMODA SUPER AI NIGHT event in Jakarta, showcasing its AI-powered cockpit technology integrated with ByteDance Seed large language model. The event highlighted the brand's strategy to ex...
AnaptysBio shifts to royalty management, focusing on growing Jemperli royalties from GSK.
AnaptysBio has transformed into a royalty management company centered on Jemperli, an oncology drug commercialized by GSK. The company now operates with minimal costs, targeting a 95% EBIT margin and holding over $140 million in net cash, eliminating...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.